Related references
Note: Only part of the references are listed.Vital Signs, QT Prolongation, and Newly Diagnosed Cardiovascular Disease During Severe Hypoglycemia in Type 1 and Type 2 Diabetic Patients
Tetsuro Tsujimoto et al.
DIABETES CARE (2014)
Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis
Atsushi Goto et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers
Miyako Kishimoto et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up
Franco Cavalot et al.
DIABETES CARE (2011)
Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes
Mi K. Kim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Impact of acute hyperglycaemia on endothelial function and retinal vascular reactivity in patients with Type 2 diabetes
M. V. Chittari et al.
DIABETIC MEDICINE (2011)
Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin A proof-of-concept study
Sabine Arnolds et al.
DIABETES CARE (2010)
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
J. Rosenstock et al.
DIABETOLOGIA (2008)
Distribution of Blood Glucose and the Correlation between Blood Glucose and Hemoglobin A1c Levels in Diabetic Outpatients
Ritsuko Yamamoto-Honda et al.
ENDOCRINE JOURNAL (2008)
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
Reinhard G. Bretzel et al.
LANCET (2008)
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study
Naoki Kumashiro et al.
ENDOCRINE JOURNAL (2007)
Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats
Y. Mori et al.
ENDOCRINE (2006)
Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
H Yki-Järvinen et al.
DIABETOLOGIA (2006)
Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus
T Yoshihara et al.
ENDOCRINE JOURNAL (2006)
Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients
T Shiraiwa et al.
DIABETES CARE (2005)
Postprandial glucose regulation and diabetic complications
A Ceriello et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics
A Lee et al.
DIABETES OBESITY & METABOLISM (2002)
Morning hyperglycemic excursions - A constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes
L Monnier et al.
DIABETES CARE (2002)
Share Paper
